Correlation Between Bank Central and Medtech Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Central and Medtech Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Medtech Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Central Asia and Medtech Acquisition Corp, you can compare the effects of market volatilities on Bank Central and Medtech Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Medtech Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Medtech Acquisition.

Diversification Opportunities for Bank Central and Medtech Acquisition

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bank and Medtech is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Medtech Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medtech Acquisition Corp and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Medtech Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medtech Acquisition Corp has no effect on the direction of Bank Central i.e., Bank Central and Medtech Acquisition go up and down completely randomly.

Pair Corralation between Bank Central and Medtech Acquisition

If you would invest  1,429  in Bank Central Asia on September 1, 2024 and sell it today you would earn a total of  132.00  from holding Bank Central Asia or generate 9.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy0.79%
ValuesDaily Returns

Bank Central Asia  vs.  Medtech Acquisition Corp

 Performance 
       Timeline  
Bank Central Asia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Bank Central is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Medtech Acquisition Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medtech Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Medtech Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Bank Central and Medtech Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Central and Medtech Acquisition

The main advantage of trading using opposite Bank Central and Medtech Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Medtech Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medtech Acquisition will offset losses from the drop in Medtech Acquisition's long position.
The idea behind Bank Central Asia and Medtech Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.